AFT Forsyth & Company’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,753
| Closed | -$2.17M | – | 129 |
|
|
2025
Q4 | $2.17M | Buy |
+3,753
| New | +$2.12M | 0.94% | 22 |
|
|
2025
Q2 | – | Sell |
-3,708
| Closed | -$1.85M | – | 128 |
|
|
2025
Q1 | $1.85M | Sell |
3,708
-165
| -4% | -$89.4K | 0.99% | 24 |
|
|
2024
Q4 | $2.01M | Buy |
3,873
+15
| +0.4% | +$8.25K | 0.99% | 23 |
|
|
2024
Q3 | $2.39M | Buy |
3,858
+807
| +26% | +$478K | 1.18% | 21 |
|
|
2024
Q2 | $1.69M | Buy |
3,051
+335
| +12% | +$192K | 0.83% | 29 |
|
|
2024
Q1 | $1.58M | Sell |
2,716
-175
| -6% | -$98.2K | 0.9% | 30 |
|
|
2023
Q4 | $1.53M | Buy |
2,891
+10
| +0.3% | +$4.84K | 0.97% | 26 |
|
|
2023
Q3 | $1.46M | Buy |
2,881
+75
| +3% | +$40K | 1.07% | 22 |
|
|
2023
Q2 | $1.46M | Sell |
2,806
-110
| -4% | -$59.4K | 1.04% | 22 |
|
|
2023
Q1 | $1.68M | Sell |
2,916
-90
| -3% | -$50.7K | 1.3% | 16 |
|
|
2022
Q4 | $1.66M | Sell |
3,006
-395
| -12% | -$209K | 1.41% | 17 |
|
|
2022
Q3 | $1.73M | Sell |
3,401
-150
| -4% | -$83.9K | 1.54% | 15 |
|
|
2022
Q2 | $1.93M | Buy |
3,551
+5
| +0.1% | +$2.75K | 1.56% | 15 |
|
|
2022
Q1 | $2.1M | Buy |
3,546
+100
| +3% | +$57.4K | 1.33% | 16 |
|
|
2021
Q4 | $2.3M | Sell |
3,446
-120
| -3% | -$74.9K | 1.18% | 18 |
|
|
2021
Q3 | $2.04M | Hold |
3,566
| – | – | 1.09% | 21 |
|
|
2021
Q2 | $1.8M | Buy |
3,566
+150
| +4% | +$70.8K | 0.96% | 23 |
|
|
2021
Q1 | $1.56M | Buy |
3,416
+165
| +5% | +$78.8K | 0.93% | 27 |
|
|
2020
Q4 | $1.51M | Buy |
3,251
+225
| +7% | +$105K | 0.95% | 28 |
|
|
2020
Q3 | $1.34M | Sell |
3,026
-5
| -0.2% | -$2.07K | 0.99% | 25 |
|
|
2020
Q2 | $1.1M | Sell |
3,031
-500
| -14% | -$168K | 0.93% | 31 |
|
|
2020
Q1 | $1M | Sell |
3,531
-35
| -1% | -$11K | 1.01% | 28 |
|
|
2019
Q4 | $1.16M | Buy |
3,566
+405
| +13% | +$123K | 0.88% | 38 |
|
|
2019
Q3 | $921K | Buy |
3,161
+205
| +7% | +$58.7K | 0.76% | 48 |
|
|
2019
Q2 | $868K | Buy |
2,956
+335
| +13% | +$92.3K | 0.72% | 50 |
|
|
2019
Q1 | $717K | Buy |
2,621
+235
| +10% | +$58.5K | 0.62% | 60 |
|
|
2018
Q4 | $534K | Buy |
2,386
+3
| +0.1% | +$704 | 0.53% | 66 |
|
|
2018
Q3 | $582K | Buy |
2,383
+850
| +55% | +$196K | 0.48% | 76 |
|
|
2018
Q2 | $318K | Buy |
1,533
+83
| +6% | +$17.6K | 0.28% | 113 |
|
|
2018
Q1 | $299K | Hold |
1,450
| – | – | 0.28% | 111 |
|
|
2017
Q4 | $275K | Buy |
+1,450
| New | +$278K | 0.27% | 113 |
|
|
2013
Q3 | $85K | Buy |
920
+125
| +16% | +$11.3K | 0.11% | 145 |
|
|
2013
Q2 | $67K | Buy |
+795
| New | +$66.2K | 0.1% | 147 |
|
Other funds holding TMO
VCM
AFT Forsyth & Company's TMO Position: Q1 2026 in Review
AFT Forsyth & Company sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 3,753 shares — an estimated $2.17M sold.
AFT Forsyth & Company first reported a position in TMO in Q2 2013 and held it in 33 quarters. The position peaked at $2.39M in Q3 2024. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- AFT Forsyth & Company reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
- AFT Forsyth & Company sold 3,753 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.17M.
- AFT Forsyth & Company first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 33 quarters.
- AFT Forsyth & Company's Thermo Fisher Scientific position peaked at $2.39M in Q3 2024.
- 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on AFT Forsyth & Company's 13F filing for Q1 2026, filed 14 May 2026.